List of Excipients in API oxymetazoline hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing oxymetazoline hydrochloride
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | RHOFADE | oxymetazoline hydrochloride | 0023-5300 | ANHYDROUS CITRIC ACID | |
Allergan Inc | RHOFADE | oxymetazoline hydrochloride | 0023-5300 | BUTYLATED HYDROXYTOLUENE | |
Allergan Inc | RHOFADE | oxymetazoline hydrochloride | 0023-5300 | CETEARETH-25 | |
Allergan Inc | RHOFADE | oxymetazoline hydrochloride | 0023-5300 | CETEARETH-6 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing oxymetazoline hydrochloride
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 | ANHYDROUS CITRIC ACID |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 | BUTYLATED HYDROXYTOLUENE |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 | CETEARETH-25 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 | CETEARETH-6 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for oxymetazoline hydrochloride
Excipient focus: ANHYDROUS CITRIC ACID
oxymetazoline hydrochloride drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
oxymetazoline hydrochloride drug variants containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing BUTYLATED HYDROXYTOLUENE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM CHLORIDE
oxymetazoline hydrochloride drug variants containing CALCIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing CALCIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: CETEARETH-25
oxymetazoline hydrochloride drug variants containing CETEARETH-25
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing CETEARETH-25
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: CETEARETH-6
oxymetazoline hydrochloride drug variants containing CETEARETH-6
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing CETEARETH-6
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
oxymetazoline hydrochloride drug variants containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing CETOSTEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: DIISOPROPYL ADIPATE
oxymetazoline hydrochloride drug variants containing DIISOPROPYL ADIPATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing DIISOPROPYL ADIPATE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
oxymetazoline hydrochloride drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCOL STEARATE
oxymetazoline hydrochloride drug variants containing GLYCOL STEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
EPI Health LLC | oxymetazoline hydrochloride | 71403-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing GLYCOL STEARATE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROCHLORIC ACID
oxymetazoline hydrochloride drug variants containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing HYDROCHLORIC ACID
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
oxymetazoline hydrochloride drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: LANOLIN
oxymetazoline hydrochloride drug variants containing LANOLIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing LANOLIN
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CHLORIDE
oxymetazoline hydrochloride drug variants containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing MAGNESIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
oxymetazoline hydrochloride drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
oxymetazoline hydrochloride drug variants containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing METHYLPARABEN
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: OLEYL ALCOHOL
oxymetazoline hydrochloride drug variants containing OLEYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing OLEYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: PEG-32 STEARATE
oxymetazoline hydrochloride drug variants containing PEG-32 STEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
EPI Health LLC | oxymetazoline hydrochloride | 71403-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing PEG-32 STEARATE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: PEG-6 STEARATE
oxymetazoline hydrochloride drug variants containing PEG-6 STEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
EPI Health LLC | oxymetazoline hydrochloride | 71403-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing PEG-6 STEARATE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: PHENOXYETHANOL
oxymetazoline hydrochloride drug variants containing PHENOXYETHANOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing PHENOXYETHANOL
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 300
oxymetazoline hydrochloride drug variants containing POLYETHYLENE GLYCOL 300
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing POLYETHYLENE GLYCOL 300
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 60
oxymetazoline hydrochloride drug variants containing POLYSORBATE 60
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing POLYSORBATE 60
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
EPI Health LLC | oxymetazoline hydrochloride | 71403-003 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
oxymetazoline hydrochloride drug variants containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
oxymetazoline hydrochloride drug variants containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing PROPYLPARABEN
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM ACETATE
oxymetazoline hydrochloride drug variants containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing SODIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CHLORIDE
oxymetazoline hydrochloride drug variants containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing SODIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
oxymetazoline hydrochloride drug variants containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing SODIUM CITRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
oxymetazoline hydrochloride drug variants containing SORBITAN MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing SORBITAN MONOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
EPI Health LLC | oxymetazoline hydrochloride | 71403-003 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
oxymetazoline hydrochloride drug variants containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing STEARYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: TRISODIUM CITRATE DIHYDRATE
oxymetazoline hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Company | Ingredient | NDC |
---|---|---|
RVL Pharmaceuticals Inc | oxymetazoline hydrochloride ophthalmic | 73687-062 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
oxymetazoline hydrochloride drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | oxymetazoline hydrochloride | 0023-5300 |
Taro Pharmaceuticals USA Inc | oxymetazoline hydrochloride | 51672-1405 |
Mayne Pharma | oxymetazoline hydrochloride | 51862-765 |
Aclaris Therapeutics Inc | oxymetazoline hydrochloride | 71180-003 |
>Company | >Ingredient | >NDC |
oxymetazoline hydrochloride drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.